201 related articles for article (PubMed ID: 34094839)
1. Mechanism of allosteric activation of SIRT6 revealed by the action of rationally designed activators.
Lu S; Chen Y; Wei J; Zhao M; Ni D; He X; Zhang J
Acta Pharm Sin B; 2021 May; 11(5):1355-1361. PubMed ID: 34094839
[TBL] [Abstract][Full Text] [Related]
2. Targeting a cryptic allosteric site of SIRT6 with small-molecule inhibitors that inhibit the migration of pancreatic cancer cells.
Zhang Q; Chen Y; Ni D; Huang Z; Wei J; Feng L; Su JC; Wei Y; Ning S; Yang X; Zhao M; Qiu Y; Song K; Yu Z; Xu J; Li X; Lin H; Lu S; Zhang J
Acta Pharm Sin B; 2022 Feb; 12(2):876-889. PubMed ID: 35256952
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of activation for the sirtuin 6 protein deacylase.
Klein MA; Liu C; Kuznetsov VI; Feltenberger JB; Tang W; Denu JM
J Biol Chem; 2020 Jan; 295(5):1385-1399. PubMed ID: 31822559
[TBL] [Abstract][Full Text] [Related]
4. Small-molecule activating SIRT6 elicits therapeutic effects and synergistically promotes anti-tumor activity of vitamin D
Shang J; Zhu Z; Chen Y; Song J; Huang Y; Song K; Zhong J; Xu X; Wei J; Wang C; Cui L; Liu CY; Zhang J
Theranostics; 2020; 10(13):5845-5864. PubMed ID: 32483423
[TBL] [Abstract][Full Text] [Related]
5. Deciphering the Allosteric Activation Mechanism of SIRT6 Using Molecular Dynamics Simulations.
Zhao Z; Du J; Du Y; Gao Y; Yu M; Zhang Y; Fang H; Hou X
J Chem Inf Model; 2023 Sep; 63(18):5896-5902. PubMed ID: 37653718
[TBL] [Abstract][Full Text] [Related]
6. Identification of a cellularly active SIRT6 allosteric activator.
Huang Z; Zhao J; Deng W; Chen Y; Shang J; Song K; Zhang L; Wang C; Lu S; Yang X; He B; Min J; Hu H; Tan M; Xu J; Zhang Q; Zhong J; Sun X; Mao Z; Lin H; Xiao M; Chin YE; Jiang H; Xu Y; Chen G; Zhang J
Nat Chem Biol; 2018 Dec; 14(12):1118-1126. PubMed ID: 30374165
[TBL] [Abstract][Full Text] [Related]
7. Discovery of cryptic allosteric sites using reversed allosteric communication by a combined computational and experimental strategy.
Ni D; Wei J; He X; Rehman AU; Li X; Qiu Y; Pu J; Lu S; Zhang J
Chem Sci; 2020 Nov; 12(1):464-476. PubMed ID: 34163609
[TBL] [Abstract][Full Text] [Related]
8. High glucose-induced oxidative stress represses sirtuin deacetylase expression and increases histone acetylation leading to neural tube defects.
Yu J; Wu Y; Yang P
J Neurochem; 2016 May; 137(3):371-83. PubMed ID: 26896748
[TBL] [Abstract][Full Text] [Related]
9.
Jos S; Aouti S; Unni S; Haridass V; Gogoi H; Deshmukh P; Padmanabhan B; Padavattan S
J Biomol Struct Dyn; 2022; 40(20):10033-10044. PubMed ID: 34121619
[TBL] [Abstract][Full Text] [Related]
10. Nitro-fatty acids as activators of hSIRT6 deacetylase activity.
Carreño M; Bresque M; Machado MR; Santos L; Durán R; Vitturi DA; Escande C; Denicola A
J Biol Chem; 2020 Dec; 295(52):18355-18366. PubMed ID: 33122195
[TBL] [Abstract][Full Text] [Related]
11. SIRT6 in Vascular Diseases, from Bench to Bedside.
Ren SC; Chen X; Gong H; Wang H; Wu C; Li PH; Chen XF; Qu JH; Tang X
Aging Dis; 2022 Jul; 13(4):1015-1029. PubMed ID: 35855341
[TBL] [Abstract][Full Text] [Related]
12. Biological and catalytic functions of sirtuin 6 as targets for small-molecule modulators.
Klein MA; Denu JM
J Biol Chem; 2020 Aug; 295(32):11021-11041. PubMed ID: 32518153
[TBL] [Abstract][Full Text] [Related]
13. A crucial role of SUMOylation in modulating Sirt6 deacetylation of H3 at lysine 56 and its tumor suppressive activity.
Cai J; Zuo Y; Wang T; Cao Y; Cai R; Chen FL; Cheng J; Mu J
Oncogene; 2016 Sep; 35(37):4949-56. PubMed ID: 26898756
[TBL] [Abstract][Full Text] [Related]
14. Trichostatin A inhibits deacetylation of histone H3 and p53 by SIRT6.
Wood M; Rymarchyk S; Zheng S; Cen Y
Arch Biochem Biophys; 2018 Jan; 638():8-17. PubMed ID: 29233643
[TBL] [Abstract][Full Text] [Related]
15. Kinetic and Structural Basis for Acyl-Group Selectivity and NAD(+) Dependence in Sirtuin-Catalyzed Deacylation.
Feldman JL; Dittenhafer-Reed KE; Kudo N; Thelen JN; Ito A; Yoshida M; Denu JM
Biochemistry; 2015 May; 54(19):3037-3050. PubMed ID: 25897714
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for the activation and inhibition of Sirtuin 6 by quercetin and its derivatives.
You W; Zheng W; Weiss S; Chua KF; Steegborn C
Sci Rep; 2019 Dec; 9(1):19176. PubMed ID: 31844103
[TBL] [Abstract][Full Text] [Related]
17. A Chemical Biology Approach to Reveal Sirt6-targeted Histone H3 Sites in Nucleosomes.
Wang WW; Zeng Y; Wu B; Deiters A; Liu WR
ACS Chem Biol; 2016 Jul; 11(7):1973-81. PubMed ID: 27152839
[TBL] [Abstract][Full Text] [Related]
18. Effect of quercetin on the protein-substrate interactions in SIRT6: Insight from MD simulations.
Zhang H; Zhang J; Zhang HX
J Mol Graph Model; 2024 Jul; 130():108778. PubMed ID: 38652998
[TBL] [Abstract][Full Text] [Related]
19. Structural Basis for Activation of Human Sirtuin 6 by Fluvastatin.
You W; Steegborn C
ACS Med Chem Lett; 2020 Nov; 11(11):2285-2289. PubMed ID: 33214841
[TBL] [Abstract][Full Text] [Related]
20. Studying SIRT6 regulation using H3K56 based substrate and small molecules.
Kokkonen P; Rahnasto-Rilla M; Mellini P; Jarho E; Lahtela-Kakkonen M; Kokkola T
Eur J Pharm Sci; 2014 Oct; 63():71-6. PubMed ID: 25004411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]